These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Active specific immunotherapy for acute myelogenous leukaemia. Powles R Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353 [No Abstract] [Full Text] [Related]
28. Activated macrophages and the antitumor action of BCG. Alexander P Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313 [No Abstract] [Full Text] [Related]
29. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy. Song CW; Levitt SH Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655 [No Abstract] [Full Text] [Related]
30. The immunological aspects of malignant disease. Oliver RT Practitioner; 1975 Apr; 214(1282):511-521. PubMed ID: 49889 [No Abstract] [Full Text] [Related]
32. [Immunotherapy of cancer with BCG]. Yamamura Y; Azuma I Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604 [No Abstract] [Full Text] [Related]
33. [Specific active immunotherapy of cancer]. Valladares Y An R Acad Nac Med (Madr); 1982; 99(1):109-46. PubMed ID: 6181704 [No Abstract] [Full Text] [Related]
35. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report. Nathanson L; Clark DA Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321 [No Abstract] [Full Text] [Related]